7 insiders reported 43 Form 4 transactions for Replimune Group, Inc. (REPL) over the past 18 months (most recent 2026-08-24). Recent activity: Astley-Sparke Philip (Director) Sell 50,000 shares, Hill Emily Luisa (Chief Financial Officer) Sell 9,256 shares, Hill Emily Luisa (Chief Financial Officer) Sell 11,448 shares, Patel Sushil (Chief Executive Officer) Sell 39,341 shares, Xynos Konstantinos (Chief Medical Officer) Sell 11,447 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Astley-Sparke Philip | Director | Sell | 50,000 | $0 |
| 2026-08-19 | Hill Emily Luisa | Chief Financial Officer | Sell | 9,256 | $132,176 |
| 2026-08-12 | Hill Emily Luisa | Chief Financial Officer | Sell | 11,448 | $148,481 |
| 2026-08-12 | Patel Sushil | Chief Executive Officer | Sell | 39,341 | $510,253 |
| 2026-08-12 | Xynos Konstantinos | Chief Medical Officer | Sell | 11,447 | $148,468 |
| 2026-08-12 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,632 | $98,987 |
| 2026-06-03 | Sarchi Christopher | Chief Commercial Officer | Sell | 12,000 | $110,880 |
| 2026-05-20 | Schwendenman Andrew | Chief Accounting Officer | Sell | 7,894 | $40,102 |
| 2026-05-20 | Patel Sushil | Chief Executive Officer | Sell | 37,324 | $189,606 |
| 2026-05-20 | Xynos Konstantinos | Chief Medical Officer | Sell | 14,023 | $71,237 |
| 2026-05-20 | Hill Emily Luisa | Chief Financial Officer | Sell | 7,812 | $39,685 |
| 2026-05-20 | Astley-Sparke Philip | Director | Sell | 17,657 | $89,698 |
| 2026-05-20 | Sarchi Christopher | Chief Commercial Officer | Sell | 8,626 | $43,820 |
| 2026-04-07 | Sarchi Christopher | Chief Commercial Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Astley-Sparke Philip | Director | Buy | 50,000 | $0 |
| 2026-04-07 | Xynos Konstantinos | Chief Medical Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Hill Emily Luisa | Chief Financial Officer | Buy | 50,000 | $0 |
| 2026-04-07 | Patel Sushil | Chief Executive Officer | Buy | 251,240 | $0 |
| 2026-04-07 | Schwendenman Andrew | Chief Accounting Officer | Sell | 36,667 | $0 |
| 2026-04-06 | Sarchi Christopher | Chief Commercial Officer | Sell | 6,500 | $52,065 |
| 2026-02-20 | Astley-Sparke Philip | Director | Sell | 25,000 | $0 |
| 2025-12-19 | Schwendenman Andrew | Chief Accounting Officer | Buy | 10,000 | $0 |
| 2025-12-19 | Patel Sushil | Chief Executive Officer | Buy | 200,000 | $0 |
| 2025-12-19 | Xynos Konstantinos | Chief Medical Officer | Buy | 60,000 | $0 |
| 2025-12-19 | Hill Emily Luisa | Chief Financial Officer | Buy | 60,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-24